| Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
|---|
| 07/20/2005 | CN1643133A Chimeric pancreas |
| 07/20/2005 | CN1642967A Clinical grade vectors based on natural microflora for use in delivering therapeutic compositions |
| 07/20/2005 | CN1642579A Methods and composition for delivering nucleic acids and/or proteins to the intestinal mucosa |
| 07/20/2005 | CN1642563A Compositions and methods for treatment of skin disorders |
| 07/20/2005 | CN1642562A Purified cytokine inhibitory factor |
| 07/20/2005 | CN1642561A Compositions containing labile bioactive materials, methods of preparation and treatment |
| 07/20/2005 | CN1642560A Hyaluronic acid mediated adenoviral transduction |
| 07/20/2005 | CN1642437A Probiotic delivery system |
| 07/20/2005 | CN1641015A Bifidobacterium and its use |
| 07/20/2005 | CN1641014A Acidophilic lactobacillus and its use |
| 07/20/2005 | CN1640489A Method for preparing urine polyacid peptide composition |
| 07/20/2005 | CN1640413A Pearl nourishing health-care vinegar oral liquid and its preparing method |
| 07/20/2005 | CN1211386C Antitumoral analogue of Et-743 |
| 07/20/2005 | CN1211126C Vascular endothelial growth factor 2 |
| 07/20/2005 | CN1211118C Formula of medicine for treating bone fracture |
| 07/20/2005 | CN1211117C Preparation of Xinxue granules |
| 07/20/2005 | CN1211116C Medicine for treating sympthetic nerve disorder |
| 07/20/2005 | CN1211115C Chinese materia medica preparation for treating burn and scald and method for preparing the same |
| 07/20/2005 | CN1211112C Gubenhuiyuan traditional Chinese medicine composition and its method for producing oral liquid |
| 07/20/2005 | CN1211110C Chinese medicine composition for treating tumour and preparation method |
| 07/20/2005 | CN1211108C Chinese patent drug for treating thrombus obliterating angiitis |
| 07/20/2005 | CN1211103C Oral taken and external use medicine for antirheumatism and stopping numbness pain and preparation method |
| 07/20/2005 | CN1211102C Chinese medicine capsule for curing facial acne and preparation method |
| 07/20/2005 | CN1211100C Compound composite medicine for giving up drug-addiction |
| 07/20/2005 | CN1211099C Zhenggutongbi pill for treating bone disunion, aseptic bone necrosis and chronic osteomyelitis and its preparing method |
| 07/20/2005 | CN1211093C Powder prepared from snake tissues for soaking feet |
| 07/20/2005 | CN1211072C Snake wine |
| 07/20/2005 | CN1211070C Facial tissue compsn. and method of use for sequestration of nasal secretion skin irritants |
| 07/19/2005 | US6919187 Comprises polypeptides for use in serodiagnosis and treatment of chlamydial sexually transmitted disease; vaccines |
| 07/19/2005 | US6919075 Bacteriophage displaying aβ epitopes and method of use |
| 07/14/2005 | WO2005064021A2 Vaccine |
| 07/14/2005 | WO2005063969A2 Methods for the identification and preparation of regulator/suppressor t lymphocytes, compositions and uses thereof |
| 07/14/2005 | WO2005063801A2 Method for decreasing the contact between hepta-repeat region s of the corona-virus spike proteins and use thereof |
| 07/14/2005 | WO2005063314A1 Decellularized tissue and method of preparing the same |
| 07/14/2005 | WO2005063303A1 Use of human cord blood-derived pluripotent cells for the treatment of disease |
| 07/14/2005 | WO2005063302A1 Drug for preventing or treating heart diseases comprising cd9 gene |
| 07/14/2005 | WO2005063265A1 Active oxygen scavenger containing oceanic deep-layer water as active ingredient, dilution of oceanic deep-layer water having active oxygen scavenging capability and beverage having active oxygen scavenging capability |
| 07/14/2005 | WO2005063200A2 Probiotic tablet formulations |
| 07/14/2005 | WO2005063196A1 Skin moisturizing agent for oral intake and functional foods and drinks |
| 07/14/2005 | WO2005062962A2 Methods and compositions for directing migration of neural progenitor cells |
| 07/14/2005 | WO2005062878A2 Canine probiotic bifidobacteria globosum |
| 07/14/2005 | WO2005062820A2 Multi plasmid system for the production of influenza virus |
| 07/14/2005 | WO2005062791A2 Utilization of stem cell and fibroblast combined products and nutrients in topical compositions |
| 07/14/2005 | WO2005037144A3 Methods and compositions for growing corneal endothelial and related cells on biopolymers and creation of artifical corneal transplants |
| 07/14/2005 | WO2005010149A3 Subgroup b adenoviral vectors for treating disease |
| 07/14/2005 | WO2004078927A3 Progenitor cells and methods of using same |
| 07/14/2005 | US20050154458 Apparatus for the regeneration of human tissue |
| 07/14/2005 | US20050153906 Such as Hurler syndrome and Batten by administering an aminoglycosidesuch as gentamicin, G418, hygromycin B, paromomycin, tobramycin, lividomycin A, amikacin, sisomycin, or neomycin, optionally in combination with an enzyme effective for enzyme replacement therapy, a polyionic compound or gene therapy |
| 07/14/2005 | US20050153891 proteins coded by murine herpes viruses, or homologues, use in binding chemokines, to produce an immunomodulatory or antiinflammatory effects |
| 07/14/2005 | US20050153886 nucleotide sequences comprising cDNA and genomic DNA that code for angiogenesis factors, used for gene therapy |
| 07/14/2005 | US20050153873 Frequency assisted transdermal agent delivery method and system |
| 07/14/2005 | US20050153483 Carrier, method of manufacturing a carrier and an electronic device |
| 07/14/2005 | US20050153447 Closed culture vessel comprising inlet and outlet filters for use in propagation of lymphocytes; bioreactors |
| 07/14/2005 | US20050153445 System for expanding and differentiating human embryonic stem cells |
| 07/14/2005 | US20050153444 Using fibroblast growth factor to establish a line of embryonic stem cells |
| 07/14/2005 | US20050153443 Using cell mass, pluripotent and/or multipotent stem cells to propagate preferential mammalian cells or tissues; regenerative medicine; tissue engineering; tissue targeted therapy |
| 07/14/2005 | US20050153442 Adipose-derived stem cells and lattices |
| 07/14/2005 | US20050153441 Adipose-derived stem cells and lattices |
| 07/14/2005 | US20050153389 Method for the production of bioactive substances from the novel actinomycete taxon MAR2 ("Marinophilus") |
| 07/14/2005 | US20050153342 Using cell-adhesion matrix to isolate and propagate tumlor cells; blood filters |
| 07/14/2005 | US20050153329 Method for determining immune system affecting compounds |
| 07/14/2005 | US20050153018 pellets comprising compacted inner matrices containing viable microorganisms and moisture barrier coatings |
| 07/14/2005 | US20050152985 The use of Colostrinin as a medicament, particularly in the treatment of chronic disorders of the central nervous system and the immune system. |
| 07/14/2005 | US20050152966 For controlled release of lyophilized probiotic bacterium; compressed tablets |
| 07/14/2005 | US20050152952 Phaseolamin compositions and methods for using the same |
| 07/14/2005 | US20050152916 Antigen presenting system and methods for activation of T-cells |
| 07/14/2005 | US20050152915 Exposure of tumor cells obtained ex vivo or pathological cells of a non-tumorous nature or of a biological fluid of a mammal containing viruses or bacteria to radiation of the optical range, the administering them into the lymphatic system ; enhances the efficacy and usability of immunotherapy |
| 07/14/2005 | US20050152897 Methods for inducing T cell tolerance to a tissue or organ graft |
| 07/14/2005 | US20050152884 strains of lactic acid bacteria obtained by isolation from mammallian gastrointestinal systems having probiotic activity in animals; animal feeds |
| 07/14/2005 | US20050152883 isolation of ligament cells, then culturing, recovering and implanting the cells into patients |
| 07/14/2005 | US20050152882 Particulate cartilage system |
| 07/14/2005 | US20050152881 Composition of matrix suitable for implantation in humans defatting shredded allogenic human muscle tissues |
| 07/14/2005 | US20050152878 Agents and compositions and methods utilizing same useful in diagnosing and/or treating or preventing plaque forming diseases |
| 07/14/2005 | US20050152871 treating the subject in need with one or more chemokines and/or a DNA damaging agent inducing said chemokine(s); |
| 07/14/2005 | US20050152867 Skin-care and hair care composition of cumin, cloves, olibanum, eagle wood, and giant hyssop; cleanser, a deodorant, treating skin problems, wrinkles, skin sagging, dark spots, skin infections, skin irritation, cuts, scarring, acne, cold sores |
| 07/14/2005 | CA2807342A1 Definitive endoderm |
| 07/14/2005 | CA2551581A1 Probiotic tablet formulations |
| 07/14/2005 | CA2551489A1 Multi plasmid system for the production of influenza virus |
| 07/14/2005 | CA2550927A1 A gram negative bacterium with reduced lps level in the outer membrane and use thereof for treating gram negative bacterial infection |
| 07/14/2005 | CA2550383A1 Methods and compositions for directing migration of neural progenitor cells |
| 07/14/2005 | CA2550326A1 Use of human cord blood-derived pluripotent cells for the treatment of disease |
| 07/14/2005 | CA2550309A1 Canine probiotic bifidobacteria pseudolongum |
| 07/14/2005 | CA2550307A1 Canine probiotic bifidobacteria globosum |
| 07/14/2005 | CA2549703A1 Skin moisturizing agent for oral intake and functional foods and drinks |
| 07/14/2005 | CA2549394A1 Methods for the identification and preparation of regulator/suppressor t lymphocytes, compositions and uses thereof |
| 07/13/2005 | EP1553182A2 Regulated genes and uses thereof |
| 07/13/2005 | EP1553178A1 Tumor-lysing virus growing selectively in tumor cells |
| 07/13/2005 | EP1553168A2 Methods for selectively stimulating proliferation of T cells |
| 07/13/2005 | EP1552852A1 Inhibition of proliferation and infiltration of brain tumor cells caused by expression of ampa-type glutamate receptor subunit |
| 07/13/2005 | EP1552848A1 Compositions against chicken coccidiosis |
| 07/13/2005 | EP1552843A1 Dioxin elimination promoter |
| 07/13/2005 | EP1552838A1 Rubrofusarin glycoside-containing composition |
| 07/13/2005 | EP1552269A2 Formaldehyde-ammonium salt complexes for the stabilization of blood cells |
| 07/13/2005 | EP1552018A2 Methods and compositions relating to gene silencing |
| 07/13/2005 | EP1551990A2 Diagnosis and treatment of chemoresistant tumors |
| 07/13/2005 | EP1551970A2 Stem cell expansion factor blocking a gene limiting hox-induced expansion and method using such factor |
| 07/13/2005 | EP1551955A2 Methods of implanting mesenchymal stem cells for tissue repair and formation |
| 07/13/2005 | EP1551953A2 Modulation of stem and progenitor cell differentiation, assays, and uses thereof |
| 07/13/2005 | EP1551952A1 Selection and use of lactic acid bacteria for reducing inflammation caused by helicobacter |
| 07/13/2005 | EP1551449A1 Reagents and methods for engaging unique clonotypic lymphocyte receptors |